Science Explorer Back to mapMap
Discussion
Company · Worcester · United States

BioPAL (United States)

biopal.comROR OpenAlex
Research works
43
▲ 24% vs 2018-21
Citations
1.8k
42.3 per fractional work
Top-10% rate
21.1%
all institutions 10.0%
Open access
37%
world 40%
International
16%
world 18%
BioPAL (United States)

Not ranked overall: BioPAL (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does BioPAL (United States) work in?

In all years, 45% of research at BioPAL (United States) is in Health Sciences, 42% in Life Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (9%). It does 2.2× the world's share of Life Sciences.

Health Sciences: 20 fractional works · 45.5% of its workMedicine: 19 fractional works · 44.7% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 10.2% of its workOncology: 4 fractional works · 10.0% of its workEpidemiology: 2 fractional works · 3.6% of its workNephrology: 1 fractional works · 3.3% of its workRheumatology: 1 fractional works · 2.8% of its workHematology: 1 fractional works · 2.0% of its workSurgery: 1 fractional works · 1.8% of its workGenetics: 1 fractional works · 1.7% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.5% of its workPhysiology: 1 fractional works · 1.5% of its workImmunology and Allergy: 0 fractional works · 1.2% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.1% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.8% of its workInfectious Diseases: 0 fractional works · 0.8% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.4% of its workOphthalmology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.8% of its workNutrition and Dietetics: 0 fractional works · 0.8% of its workLife Sciences: 18 fractional works · 42.1% of its workBiochemistry, Genetics and Molecular Biology: 13 fractional works · 30.1% of its workMolecular Biology: 10 fractional works · 23.1% of its workCancer Research: 1 fractional works · 2.0% of its workCell Biology: 1 fractional works · 1.6% of its workBiotechnology: 0 fractional works · 1.2% of its workGenetics: 0 fractional works · 1.0% of its workBiophysics: 0 fractional works · 0.8% of its workAging: 0 fractional works · 0.4% of its workImmunology and Microbiology: 4 fractional works · 9.2% of its workImmunology: 4 fractional works · 8.4% of its workVirology: 0 fractional works · 0.8% of its workNeuroscience: 1 fractional works · 2.9% of its workDevelopmental Neuroscience: 0 fractional works · 0.9% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.5% of its workCognitive Neuroscience: 0 fractional works · 0.4% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 5 fractional works · 11.6% of its workChemistry: 2 fractional works · 4.1% of its workSpectroscopy: 1 fractional works · 2.2% of its workOrganic Chemistry: 1 fractional works · 1.9% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMaterials Science: 1 fractional works · 3.0% of its workBiomaterials: 1 fractional works · 1.5% of its workMaterials Chemistry: 1 fractional works · 1.4% of its workEngineering: 1 fractional works · 2.4% of its workBiomedical Engineering: 1 fractional works · 2.4% of its workEnvironmental Science: 0 fractional works · 1.0% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.5% of its workEnvironmental Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.8% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.8% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workRadiation: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.8% of its workDecision Sciences: 0 fractional works · 0.8% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.8% of its workALL ITS WORKBioPAL (UnitedStates)43fractional works, all years
Life Sciences42%Physical Sciences12%Health Sciences45%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine1944.7%
    2. Nursing00.8%
    1. Biochemistry, Genetics and Molecular Biology1330.1%
    2. Immunology and Microbiology49.2%
    3. Neuroscience12.9%
    1. Chemistry24.1%
    2. Materials Science13.0%
    3. Engineering12.4%
    4. Environmental Science01.0%
    5. Energy00.8%
    6. Physics and Astronomy00.4%
    1. Decision Sciences00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at BioPAL (United States)?

Ranked on the quality score, Dennis E. Vaccaro lead among researchers whose main affiliation is BioPAL (United States).

  1. 1 Dennis E. Vaccaro United States · #3,572,807 worldwide 668 citations · 29 works
All ranked researchers at BioPAL (United States)

What are the most cited papers from BioPAL (United States)?

The most cited paper from BioPAL (United States) is "Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin" (Chengbin Wu, Ying Hua, Christine M. Grinnell et al., 2007), with 345 citations. Next come "Regulation of Protein Phosphatase 2A Activity by Caspase-3 during Apoptosis" (152) and "Stable labeled microspheres to measure perfusion: validation of a neutron activation assay technique" (136).

Most cited papers
#PaperReleasedCitations
1 Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin Chengbin Wu, Ying Hua, Christine M. Grinnell et al. · Nature Biotechnology 14 Oct 2007 345
2 Regulation of Protein Phosphatase 2A Activity by Caspase-3 during Apoptosis Maxine Fico Santoro, R. R. Annand, Molly M. Robertson et al. · Journal of Biological Chemistry Open access May 1998 152
3 Stable labeled microspheres to measure perfusion: validation of a neutron activation assay technique Christopher P. Reinhardt, Seth Dalhberg, Mark A. Tries et al. · American Journal of Physiology-Heart and Circulatory Physiology 2001 136
4 Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr–Abl signal transduction and oncogenesis Matthew B. Wilson, Steven J. Schreiner, Hyun-Jung Choi et al. · Oncogene 19 Nov 2002 134
5 Characterization of Noncovalent Complexes of Recombinant Human Monoclonal Antibody and Antigen Using Cation Exchange, Size Exclusion Chromatography, and BIAcore Ling C. Santora, Zehra Kaymakcalan, Paul Sakorafas et al. · Analytical Biochemistry Dec 2001 107
All 41 most cited papers, with filters and sorting

Which keywords describe research at BioPAL (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Glycosylation, Therapeutic Antibodies, Cancer, Antibody Engineering, Fc Receptors, Inflammation and Cancer Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation6▲ 57×3 topics
  2. Monoclonal Antibodies6▲ 89×3 topics
  3. Therapeutic Antibodies5▲ 93×2 topics
  4. Cancer4▲ 7.4×10 topics
  5. Inflammation4▲ 4.1×15 topics
  6. Antibody Engineering4▲ 85×1 topic
  7. Fc Receptors4▲ 85×1 topic
  8. Cancer Therapy2▲ 8.5×7 topics
  9. Biopharmaceuticals2▲ 75×3 topics
  10. Therapeutics2▲ 33×2 topics
  11. Immunogenicity2▲ 84×2 topics
  12. Recombinant Proteins2▲ 81×2 topics
  13. Tumor Microenvironment2▲ 13×4 topics
  14. Glycans2▲ 48×1 topic
  15. Immune System2▲ 12×2 topics
  16. Mucins2▲ 48×1 topic
  17. Protein Aggregation2▲ 47×2 topics
  18. Chromatography2▲ 122×1 topic
  19. Immunotherapy2▲ 5.2×4 topics
  20. Nanoparticles2▲ 2.6×5 topics
  21. Stability2▲ 18×1 topic
  22. Chronic Kidney Disease1▲ 13×3 topics
  23. Biomarkers1▲ 4.8×4 topics
  24. Gene Expression1▲ 5.0×5 topics
  25. RNA Interference1▲ 27×2 topics
  26. Angiogenesis1▲ 7.0×5 topics
  27. Autoantibodies1▲ 12×3 topics
  28. Epidemiology1▼ 0.70×6 topics
  29. Immune Response1▲ 4.4×3 topics
  30. Lymphoma1▲ 19×3 topics
  31. Quality of Life1▲ 2.0×3 topics
  32. TGF-ß1▲ 16×2 topics
  33. Autoimmunity1▲ 13×2 topics
  34. Biomedical Applications1▲ 2.4×3 topics
  35. Hemodialysis1▲ 34×2 topics
  36. Inflammatory Bowel Disease1▲ 24×3 topics
  37. Leukemia1▲ 37×2 topics
  38. Mass Spectrometry1▲ 12×3 topics
  39. Oxidative Stress1▲ 1.42×7 topics
  40. Cell Death1▲ 12×3 topics

Which research topics does BioPAL (United States) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and HER2/EGFR in Cancer Research.

Monoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksCAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksRenin-Angiotensin System Studies: 0 fractional worksApelin-related biomedical research: 0 fractional worksPer- and polyfluoroalkyl substances research: 0 fractional worksToxic Organic Pollutants Impact: 0 fractional worksEffects and risks of endocrine disrupting chemicals: 0 fractional works
Radiology, Nuclear Medicine and ImagingOncologyImmunologyCardiology and Cardiovascular Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
  4. 4 HER2/EGFR in Cancer Research Oncology 0 works
  5. 5 Biosimilars and Bioanalytical Methods Immunology 0 works
  6. 6 Renin-Angiotensin System Studies Cardiology and Cardiovascular Medicine 0 works
  7. 7 Apelin-related biomedical research Pharmacology 0 works
  8. 8 Per- and polyfluoroalkyl substances research Environmental Chemistry 0 works
  9. 9 Toxic Organic Pollutants Impact Health, Toxicology and Mutagenesis 0 works
  10. 10 Effects and risks of endocrine disrupting chemicals Health, Toxicology and Mutagenesis 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.9%not open63.1%

World: 40% of research is openly available.

with international co-authors15.6%domestic only84.4%

World: 18% is written across borders.

How has BioPAL (United States)'s research output changed?

Output in 2022-2025 was 24% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is BioPAL (United States) as a percentage of every work published that year, 0.0000060% in 2024.

still counting0.00020%0.00040%BioPAL (United States)0.0000043% in 20251990200020102020

Fractional works of BioPAL (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Worcester

All research institutions in Worcester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about BioPAL (United States). Posts are plain text and can be reported.